More studies are showing that medical cannabis can alleviate symptoms of multiple sclerosis (MS), according to a company that helps patients, doctors and others understand genetic conditions better.
The observation came in GeneFo’s 2018 Guide to Clinical Effects of Medical Cannabis.
Some research has suggested that cannabis strains containing cannabidiol (CBD) levels equal to or higher than tetrahydrocannabinol (THC) can help MS patients with muscle spasticity and pain. Other studies indicate that cannabis can help MS-related gastrointestinal problems, including constipation and difficulty with digestion.
Medical cannabis can also improve sleep quality and even vision, studies have indicated. They suggest that cannabis’ anti-inflammatory properties can help reduce inflammation of the optic nerve.
Despite evidence of benefits, GeneFo is concerned that cannabis is not yet legally approved for medical purposes in all states, which restrains access to treatments that could help MS patients.
The aim of the guide is to better inform patients about medical cannabis, including offering them help to navigate the legal and health systems.
In medical cannabis states, a person with a qualifying condition needs a physician’s recommendation to obtain authorization to visit dispensaries and buy cannabis products.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?